ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 140 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,333,748 | -10.9% | 1,069,814 | 0.0% | 0.32% | -12.1% |
Q2 2023 | $30,682,266 | +56.4% | 1,069,814 | +30.7% | 0.36% | +36.3% |
Q1 2023 | $19,617,959 | +53.8% | 818,438 | +8.8% | 0.27% | +56.1% |
Q4 2022 | $12,759,534 | -1.9% | 752,331 | -14.3% | 0.17% | -6.0% |
Q3 2022 | $13,005,000 | +3626.4% | 877,524 | +10294.7% | 0.18% | +2175.0% |
Q1 2021 | $349,000 | -79.2% | 8,442 | -78.4% | 0.01% | -85.5% |
Q3 2020 | $1,674,000 | -75.8% | 39,016 | -73.7% | 0.06% | -79.9% |
Q2 2020 | $6,921,000 | – | 148,083 | – | 0.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DFPG INVESTMENTS, LLC | 456,390 | $5,541,000 | 3.62% |
DAFNA Capital Management LLC | 173,914 | $1,890,000 | 0.65% |
One68 Global Capital, LLC | 19,861 | $216,000 | 0.47% |
Diametric Capital, LP | 51,982 | $565,000 | 0.41% |
ARK Investment Management | 1,383,756 | $15,041,000 | 0.38% |
EAM Investors, LLC | 52,833 | $574,000 | 0.13% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 31,404 | $341,000 | 0.05% |
Nikko Asset Management Americas, Inc. | 280,548 | $3,050,000 | 0.05% |
MGO ONE SEVEN LLC | 14,900 | $161,000 | 0.04% |
Qube Research & Technologies Ltd | 67,702 | $736,000 | 0.02% |